Loading…
Xtant Medical Holdings, Inc. is projected to rise to $0.4935 by 2027, a +15% move from its current price of $0.44. XTNT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.4291 | $0.4399 | $0.4509 | -0.03% |
| Aug 6 | $0.4246 | $0.4398 | $0.4554 | -0.05% |
| Aug 7 | $0.4212 | $0.4396 | $0.4589 | -0.08% |
| Aug 8 | $0.4183 | $0.4395 | $0.4618 | -0.11% |
| Aug 9 | $0.4158 | $0.4394 | $0.4644 | -0.13% |
| Aug 10 | $0.4135 | $0.4393 | $0.4667 | -0.16% |
| Aug 11 | $0.4114 | $0.4392 | $0.4689 | -0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.4114 | $0.4392 | $0.4689 | -0.19% |
| Week 2 | $0.3996 | $0.4383 | $0.4808 | -0.38% |
| Week 3 | $0.3906 | $0.4375 | $0.49 | -0.56% |
| Week 4 | $0.3831 | $0.4367 | $0.4978 | -0.75% |
| Week 5 | $0.3766 | $0.4359 | $0.5046 | -0.94% |
| Week 6 | $0.3706 | $0.4351 | $0.5107 | -1.12% |
| Week 7 | $0.3652 | $0.4342 | $0.5163 | -1.31% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Xtant Medical Holdings, Inc. is a healthcare company that provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its portfolio includes OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, OsteoVive Plus, and nanOss products that provide osteoconductive hydroxyapatite and extracellular matrix scaffolding.
It also offers sports allografts for ACL repairs and reconstructions, milled spinal allografts, traditional allografts across multiple specialties, and a range of cervical, thoracolumbar, interbody, and fusion systems. The company is headquartered in Belgrade, Montana.
XTNT is a healthcare stock with a market capitalization of $63.12M and a current price of $0.45 per share, ranking 4298 by market cap. The stock’s price sits within a near-term range, and the 30-day range spans from $0.3645 to $0.5556. The current outlook projects a multi-year pathway with rising average prices through 2050, including a 2026 average near $0.45 and a 2050 average around $2.26, with higher potential prices and bullish sentiment emerging in later years.
A major floor 18.9% below — a decisive break under it would weaken the trend.
The nearest floor, 11.4% below — buyers have tended to step in here.
The nearest ceiling, 4.5% above — a clean break opens room to run.
A major ceiling 31.8% above — clearing it would confirm fresh momentum.
Key XTNT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of XTNT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.432 | Buy | $0.4312 | Buy |
| MA 10 | $0.434 | Buy | $0.4324 | Buy |
| MA 20 | $0.431 | Buy | $0.4332 | Buy |
| MA 50 | $0.4402 | Sell | $0.4483 | Sell |
| MA 100 | $0.4864 | Sell | $0.4861 | Sell |
| MA 200 | $0.5852 | Sell | $0.537 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.35 | Neutral |
| Stoch RSI (14) | 1.29 | Buy |
| CCI (20) | -5.90 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -4.44 | Sell |
| Bollinger %B (20,2) | 0.48 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.08 | Sell |
| Awesome (5,34) | 0.00 | Buy |
| Ultimate (7,14,28) | 52.10 | Neutral |
| Momentum (10) | -0.02 | Sell |
| Aroon Osc (25) | 16.00 | Buy |
| Hull MA (9) | 0.43 | Buy |
| ADX (14) | 12.79 | Neutral |
| ATR (14) | 0.01 | Info |
The 30-day technical picture is NEUTRAL. RSI14 stands at 50, indicating balanced momentum near the midpoint. The stock’s near-term moving averages show SMA50 at $0.4538 and SMA200 at $0.5978, suggesting a mixed trend between short and longer-term price levels.
Immediate support is at $0.39 and resistance at $0.46, with the 30-day price range from $0.3645 to $0.5556.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.39 | $0.4298 | $0.5358 | 0% | Neutral | |
| $0.397 | $0.4935 | $0.6464 | +15% | Neutral | |
| $0.4565 | $0.5821 | $0.7892 | +35% | Bullish | |
| $0.4805 | $0.6255 | $0.8713 | +46% | Bullish | |
| $0.4998 | $0.6627 | $0.9441 | +54% | Bullish | |
| $0.4834 | $0.6517 | $0.9471 | +52% | Bullish | |
| $0.4856 | $0.6649 | $0.9835 | +55% | Bullish | |
| $0.5215 | $0.7244 | $1.09 | +69% | Bullish | |
| $0.5951 | $0.8381 | $1.28 | +95% | Bullish | |
| $0.665 | $0.9489 | $1.47 | +121% | Bullish | |
| $0.7647 | $1.16 | $1.90 | +169% | Bullish | |
| $1.31 | $2.19 | $3.91 | +410% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.39 | $0.4298 | $0.5134 | -2.32% |
| September 2026 | $0.3569 | $0.4209 | $0.5096 | -2.06% |
| October 2026 | $0.3618 | $0.4294 | $0.5249 | +2.00% |
| November 2026 | $0.3696 | $0.4409 | $0.5432 | +2.68% |
| December 2026 | $0.3603 | $0.4318 | $0.5358 | -2.06% |
Click any year to see its month-by-month XTNT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, XTNT could reach as high as $0.5358, with a base case around $0.4298 and support toward $0.39 — roughly 0% from $0.44. A consolidation phase looks the most probable path here.
Expect XTNT to range from $0.397 to $0.6464 through 2027. The $0.4935 average target implies a +15% move from current prices. That is up +15% on the projected 2026 average. Price action looks broadly range-bound.
The XTNT price prediction for 2028 points to an average of $0.5821 (low $0.4565, high $0.7892) — a potential gain of +35% on today's $0.44. Buyers look set to stay in control over this stretch.
In 2029, XTNT is projected to trade between $0.4805 and $0.8713, averaging $0.6255 — a potential gain of +46% from today's $0.44. That is up +7% on the projected 2028 average. Momentum favours further upside here.
Xtant Medical Holdings, Inc.'s 2030 outlook centres on $0.6627, within a $0.4998 to $0.9441 range. That is up +6% on the projected 2029 average. That marks a +54% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, XTNT could reach as high as $0.9471, with a base case around $0.6517 and support toward $0.4834 — roughly +52% from $0.44. Momentum favours further upside here.
Expect XTNT to range from $0.4856 to $0.9835 through 2032. The $0.6649 average target implies a +55% move from current prices. That is up +2% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The XTNT price prediction for 2033 points to an average of $0.7244 (low $0.5215, high $1.09) — a potential gain of +69% on today's $0.44. Momentum favours further upside here.
In 2034, XTNT is projected to trade between $0.5951 and $1.28, averaging $0.8381 — a potential gain of +95% from today's $0.44. That is up +16% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Xtant Medical Holdings, Inc.'s 2035 outlook centres on $0.9489, within a $0.665 to $1.47 range. That is up +13% on the projected 2034 average. That marks a +121% change versus current levels. Momentum favours further upside here.
By 2040, XTNT could reach as high as $1.90, with a base case around $1.16 and support toward $0.7647 — roughly +169% from $0.44. Buyers look set to stay in control over this stretch.
Expect XTNT to range from $1.31 to $3.91 through 2050. The $2.19 average target implies a +410% move from current prices. That is up +89% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in XTNT today (≈ 2,272.727273 XTNT) could be worth
$4,980.22
+$3,980.22 (+398%) by 2050 · US Dollar
Based on the average projected XTNT price of $2.19 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in XTNTwould be worth at today's price.
$1,000 invested in XTNT on Jul 31, 2025 (≈ 1,754.385987 XTNT) would be worth
$771.93
-$228.07 (-22.8%) today · 0.77× · US Dollar
Based on a XTNT entry price of $0.57 vs. today's $0.44.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.43 | $1,023.26 | +2.3% |
| 1 month ago | $0.42 | $1,047.62 | +4.8% |
| 3 months ago | $0.55 | $800 | -20.0% |
| 6 months ago | $0.6 | $733.33 | -26.7% |
| 1 year ago | $0.57 | $771.93 | -22.8% |
| All time (5.0y) ago | $1.29 | $341.09 | -65.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our XTNT forecast.
Our base-case forecast reaches $0.88 around 2035.
Implied market cap at $0.88: $123.43M
The long-range forecast displays a bullish trajectory from 2027 onward, with the 2027 average at $0.5296 and a max of $0.7184 (ROI 17.7%). Forecasts improve meaningfully toward 2028–2030, with 2028 average $0.6374, max $0.9022 (ROI 41.6%); 2029 average $0.6680, max $0.9773 (ROI 48.4%); and 2030 average $0.7227, max $1.09 (ROI 60.6%). By 2040, the average rises to $1.21 and the max to $2.15 (ROI 167.9%), and by 2050 the average reaches $2.26 with a max of $4.44 (ROI 402.2%).
The outlook remains bullish through 2050, but these are estimates, not guarantees, and carry inherent uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows a min of $0.5199, an average of $0.7227, and a max of $1.09 with an ROI of 60.6% and a bullish sentiment.
Forecasts indicate a rising average price from 2026 ($0.45) to 2030 ($0.7227) and beyond, with a 2050 average of $2.26 and a 402.2% ROI, but these are estimates and carry uncertainty.
Yes, the max forecasts are $2.15 in 2040 and $4.44 in 2050, with the 2050 average at $2.26 and a bullish outlook from 2027 onwards.
For 2027, the min is $0.4152, the average is $0.5296, the max is $0.7184, with an ROI of 17.7% and a NEUTRAL sentiment.
XTNT is priced at $0.45 per share with a market cap of $63.12M.
Xtant Medical Holdings, Inc. Community Discussion
0Share your Xtant Medical Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.